- Report
- June 2025
- 77 Pages
Japan
From €2187EUR$2,450USD£1,914GBP
- Report
- October 2024
- 83 Pages
Global
From €4329EUR$4,850USD£3,788GBP
- Report
- September 2024
- 89 Pages
Global
From €4329EUR$4,850USD£3,788GBP
- Report
- January 2024
- 230 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- August 2023
- 180 Pages
Global
From €3347EUR$3,750USD£2,929GBP
- Report
- August 2023
- 80 Pages
Russia
From €1339EUR$1,500USD£1,172GBP
- Report
- August 2023
- 80 Pages
Poland
From €1339EUR$1,500USD£1,172GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,200USD£3,170GBP
- Report
- January 2024
- 109 Pages
Global
From €3500EUR$4,200USD£3,170GBP
- Report
- November 2023
- 90 Pages
Global
From €3500EUR$4,200USD£3,170GBP
- Report
- November 2023
- 73 Pages
Global
From €3500EUR$4,200USD£3,170GBP
- Report
- July 2024
- 132 Pages
Global
From €848EUR$950USD£742GBP
- Book
- December 2018
North America

Whole Genome Sequencing (WGS) is a biotechnology process that involves sequencing the entire genetic material of an organism. It is used to identify genetic variations that may be associated with diseases, to study the evolution of species, and to develop new treatments and diagnostics. WGS is also used in agriculture to improve crop yields and to develop new varieties of plants.
WGS is a rapidly growing market, driven by advances in sequencing technology and the increasing availability of data. It is used in a variety of applications, including clinical diagnostics, drug discovery, and agricultural research. The market is expected to continue to grow as more applications are developed and the cost of sequencing continues to decrease.
Some companies in the WGS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, and Oxford Nanopore Technologies. Show Less Read more